Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of ZSP1273 tablets in adult uncomplicated influenza A
CTR20191373Phase 2Completed
- Sponsor
- Zhongsheng Pharma
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlatrelvir in Influenza A infection, sponsored by Zhongsheng Pharma. Started Oct 2019; status: completed.
02
Drugs
anlatrelvir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on CTR20191373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191373.